Your browser doesn't support javascript.
loading
Cancer Chemotherapy Update: Bevacizumab, Etoposide, and Cisplatin Regimen for Refractory Brain Metastases.
Mayer, Seth A; Solimando, Dominic A; Waddell, J Aubrey.
Affiliation
  • Mayer SA; Walter Reed National Military Medical Center, Bethesda, MD, USA.
  • Solimando DA; Oncology Pharmacy Services, Inc, Arlington, VA, USA.
  • Waddell JA; The University of Tennessee Health Science Center, Maryville, USA.
Hosp Pharm ; 52(6): 394-399, 2017 Jun.
Article in En | MEDLINE | ID: mdl-29276261
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hosp Pharm Year: 2017 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hosp Pharm Year: 2017 Type: Article Affiliation country: United States